Balaxi Pharmaceuticals Limited (BALAXI.NS)

INR 79.69

(0.59%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 2.58 Billion 2.39 Billion 1.76 Billion 996.79 Million 359.71 Million 61.07 Million
Total Current Assets 2.1 Billion 1.93 Billion 1.41 Billion 937.7 Million 348.61 Million 57.76 Million
Cash And Short Term Investments 622.9 Million 282.16 Million 71.92 Million 16.69 Million 40 Million 1.32 Million
Cash and Cash Equivalents 622.9 Million 282.16 Million 71.92 Million 16.69 Million 40 Million 1.32 Million
Short Term Investments 2.81 Million 2.44 Billion 1.84 Million - - -
Net Receivables 557.05 Million 550.73 Million 350.78 Million 784.3 Million 299.09 Million 56.43 Million
Inventory 821.68 Million 1.05 Billion 987.03 Million 136.17 Million 8.32 Million -56.43 Million
Other Current Assets -2 Billion 51.97 Million 277 Thousand 533 Thousand 1.19 Million 56.43 Million
Total Non-Current Assets 481.71 Million 461.58 Million 354.67 Million 59.1 Million 11.09 Million 3.31 Million
Net PPE 147.78 Million 190.15 Million 52.02 Million 11.68 Million 1.86 Million 113.5 Thousand
Good Will And Intangible Assets 261 Million 252.23 Million 241.26 Million 12.79 Million - -
Good Will 261 Million 252.23 Million 233.02 Million 12.79 Million - -
Intangible Assets 7.78 Million 9.09 Million 8.24 Million 8.24 Million - -
Long-Term Investments -2.58 Billion -2.39 Billion 44.69 Million 34.16 Million - -
Tax Assets 2.58 Billion 2.39 Billion -44.69 Million -34.16 Million 359.7 Million 61.07 Million
Other Non Current Assets 72.92 Million 19.19 Million 61.38 Million 34.62 Million -350.47 Million -57.87 Million
Other Assets - - - -13 Thousand - -
Total Liabilities 569.79 Million 567.89 Million 633.06 Million 346.99 Million 82.25 Million 25.87 Million
Total Current Liabilities 541.98 Million 531.33 Million 632.67 Million 346.92 Million 82.21 Million 25.87 Million
Account Payables 290.38 Million 364.8 Million 491.14 Million 220.57 Million 48.46 Million 20.8 Million
Tax Payables - 50.56 Million 50.56 Million 24.62 Million 24.62 Million 4.7 Million
Short Term Debt 176.61 Million 107.51 Million 36.38 Million 36.59 Million - -
Deferred Revenue 28.83 Million 50.56 Million - 88.47 Million - -
Other Current Liabilities 46.15 Million 8.45 Million 105.15 Million 1.28 Million 33.75 Million 5.07 Million
Total Non Current Liabilities 27.81 Million 36.55 Million 389 Thousand 71 Thousand 33 Thousand 200.00
Long-Term Debt 17.43 Million 25.55 Million 25.55 Million 443.81 Million -82.25 Million -
Deferred Revenue Non Current -28.4 Million 567.89 Million -25.55 Million 346.99 Million 82.25 Million 25.87 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 28.83 Million -567.89 Million 1000.00 -790.81 Million -1000.00 -25.87 Million
Other Liabilities - - - - - -
Total Equity 1.56 Billion 1.67 Billion 1.09 Billion 669.7 Million 237.45 Million 33.87 Million
Stock Holders Equity 2.01 Billion 1.82 Billion 1.13 Billion 649.79 Million 277.46 Million 35.2 Million
Common Stock 108.97 Million 101.81 Million 100 Million 100 Million 100 Million 30.4 Million
Retained Earnings 2.01 Billion 1.43 Billion 918.65 Million 436.8 Million 64.46 Million 3.17 Million
Accumulated other comprehensive income 2.01 Billion 103.43 Million 461 Thousand 461 Thousand 461 Thousand 460.6 Thousand
Common Stock Equity 2.01 Billion 1.82 Billion 1.13 Billion 649.79 Million 277.46 Million 35.2 Million
Capital Lease Obligation 17.43 Million 16.85 Million 16.85 Million - - -
Total Investments -2.58 Billion 44.69 Million 44.69 Million 34.16 Million - -
Total Debt 176.61 Million 133.06 Million 36.38 Million 36.59 Million 9.23 Million 3.19 Million
Net Debt -446.29 Million -149.1 Million -35.54 Million 19.9 Million -30.77 Million 1.86 Million

Balance Sheet Charts